Recombinant Proteins Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Recombinant proteins are used for the development of novel therapies for the treatment of severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique called as recombinant DNA (rDNA) technology. The numerous advancement in pharmacological understanding and pharmaceutical production have allowed constant development of proteins as a vital therapeutic option in variety of human diseases. The recombinant proteins are used in various areas such as multiple sclerosis, dwarfism, anemia, diabetes, rheumatoid arthritis, Crohn's disease and others.

MARKET SCOPE

The "Global Recombinant Proteins Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Recombinant Proteins market with detailed market segmentation by product and services, technique, application, end user and geography. The report provides key statistics on the market status of the leading Recombinant Proteins market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on product, the global recombinant proteins divided into hormones, cytokines, plasma protein factor, growth factors, recombinant metabolic enzymes and others
  
•   based on the basis of application, the market is segmented into drug discovery & development, biopharmaceutical production, basic research and others.
  
•   based on the basis of end user, the market is segmented into biopharmaceutical companies, academic & research institutes, contract research organizations and others
  

MARKET DYNAMICS

Drivers:

•   Growing research & development expenditure on biologic drugs
  
•   Technological advancement in production of recombinant protein and demand of recombinant therapeutic proteins
  

Restraints

•   Complex manufacturing process
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Recombinant Proteins market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Recombinant Proteins market in these regions.

IMPACT OF COVID-19 ON RECOMBINANT PROTEINS MARKET
COVID-19 virus outbreak was first observed in December 2019 in Wuhan (China), and it has spread to ~100 countries across the world, with the World Health Organization (WHO) stating it as a public health emergency.

The global impacts of COVID-19 are being felt across several markets. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. North America has been witnessing growing number of COVID-19 cases since its outbreak. For instance, according to WHO, from 3 January 2021 to 5 May 2021, there have been 32,123,136 confirmed cases of COVID-19 with 572,190 deaths. The cases are also increasing in Mexico and Canada. In Mexico, the cases have reached to 2,355,985 with 218,007 deaths. Similarly, in Canada, there are about 1,257,328 COVID cases, with 24,450 deaths reported so far.

MARKET PLAYERS

The report covers key developments in the Recombinant Proteins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Recombinant Proteins market are anticipated to lucrative growth opportunities in the future with the rising demand for Recombinant Proteins in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Recombinant Proteins market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Crown Bioscience Inc.
  
•   Prospec-Tany Technogene Ltd.
  
•   BPS Bioscience, Inc.
  
•   Novoprotein
  
•   PeproTech, Inc.
  
•   Eli Lilly and Company
  
•   Merck & Co., Inc.
  
•   Proteintech Group
  
•   GenScript
  
•   GlaxoSmithKline plc
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Recombinant Proteins Report Scope